Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this interesting session of oropharyngeal cancer in association with HPV status of the patients. In this webinar, the speaker, Dr. Ashish M Kaushal, and Dr. Tejinder Singh has shared the important facts associated with head and neck cancer.
Oropharyngeal cancers are common in men as smoking is one of the primary reasons for having this disease. Also, being infected with human papillomavirus (HPV) can increase the risk of oropharyngeal cancer. Signs and symptoms of oropharyngeal cancer include a lump in the neck and a sore throat
HPV status is associated with the occurrence of cancer at the back of the throat, including the base of the tongue and tonsils. About 70% of oropharyngeal cancers occur in HPV positive individuals. However, HPV negative patients can also have head and neck cancers. Learn more about them through case studies in this session
Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.
2.
FDA Greenlights First Engineered Cell Therapy for a Solid Tumor
3.
The FDA Approves the New Frontline Aggressive ALL Regimen.
4.
Studies point to redlining as a 'perfect storm' for breast cancer
5.
Targeted radiation therapy shows near-complete response in rare sarcoma patients
1.
The Power of Salt Tablets: Unlocking Health Benefits Beyond Sodium
2.
Neuroendocrine Tumors: Mechanisms of Mortality, Associated Conditions
3.
Revolutionizing Thyroid Cancer: Advances in Molecular Genetics and Personalized Treatment Approaches
4.
Seeing the Unseen: The Benefits of Early Stage Breast Cancer Ultrasound
5.
Unlocking the Secrets of Follicular Cells: Exploring the Potential of Stem Cell Research
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
International Lung Cancer Congress®
3.
Genito-Urinary Oncology Summit 2026
4.
Future NRG Oncology Meeting
5.
ISMB 2026 (Intelligent Systems for Molecular Biology)
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
3.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
4.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation